IL22/IL-22R pathway induces cell survival in human glioblastoma cells

PLoS ONE

Volumn 10, Issue 3, 2015, Pages

  Akil, Hussein ^a   Abbaci, Amazigh ^a   Lalloué, Fabrice ^a   Bessette, Barbara ^a   Costes, Léa M M ^a   Domballe, Linda ^a   Charreau, Sandrine ^b   Guilloteau, Karline ^b,c   Karayan Tapon, Lucie ^b,c   Bernard, François Xavier ^b,d   Morel, Franck ^b   Jauberteau, Marie Odile ^a   Lecron, Jean Claude ^b,c  

^a UNIVERSITÉ DE LIMOGES   (France)

^b UNIVERSITÉ DE POITIERS   (France)

^c POITIERS UNIVERSITY HOSPITAL   (France)

^d Laboratoire de Cancérologie Biologique CHU de Poitiers ^*  (France)

Author keywords

[No Author keywords available]

Indexed keywords

BROXURIDINE; CELL RECEPTOR; INTERLEUKIN 10 RECEPTOR; INTERLEUKIN 22; INTERLEUKIN 22 RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN BCL XL; PROTEIN KINASE B; STAT3 PROTEIN; UNCLASSIFIED DRUG; IL10RB PROTEIN, HUMAN; INTERLEUKIN 10 RECEPTOR BETA; INTERLEUKIN DERIVATIVE; INTERLEUKIN RECEPTOR; INTERLEUKIN-22; INTERLEUKIN-22 RECEPTOR;

ADULT; APOPTOSIS; ARTICLE; CARCINOGENESIS; CELL DEATH; CELL PROLIFERATION; CELL SURVIVAL; CLINICAL ARTICLE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GLIOBLASTOMA CELL LINE; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIMARY CELL LINE; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN SUBUNIT; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR INVASION; WESTERN BLOTTING; CANCER STEM CELL; GENE EXPRESSION; GENETICS; GLIOBLASTOMA; METABOLISM; PHOSPHORYLATION; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; GENE EXPRESSION; GLIOBLASTOMA; HUMANS; INTERLEUKIN-10 RECEPTOR BETA SUBUNIT; INTERLEUKINS; MAP KINASE SIGNALING SYSTEM; NEOPLASTIC STEM CELLS; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTORS, INTERLEUKIN; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR;

EID: 84925800448     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0119872     Document Type: Article

References (52)

1. Lim C, Savan R. The role of the IL-22/IL-22R1 axis in cancer. Cytokine Growth Factor Rev. 2014; 25 (3):257-71. doi: 10.1016/j.cytogfr.2014.04.005 PMID: 24856143
2. Xie MH, Aggarwal S, Ho WH, Foster J, Zhang Z, Stinson J, et al. Interleukin (IL)-22, a novel human cytokine that signals through the interferon receptor-related proteins CRF2-4 and IL-22R. J Biol Chem. 2000; 275(40):31335-9. doi: 10.1074/jbc.M005304200 PMID: 10875937
3. Kotenko SV, Izotova LS, Mirochnitchenko OV, Esterova E, Dickensheets H, Donnelly RP, et al. Identification of the functional interleukin-22 (IL-22) receptor complex: the IL-10R2 chain (IL-10Rbeta) is a common chain of both the IL-10 and IL-22 (IL-10-related T cell-derived inducible factor, IL-TIF) receptor complexes. J Biol Chem. 2001; 276(4):2725-32. doi: 10.1074/jbc.M007837200 PMID: 11035029
4. Dumoutier L, Louahed J, Renauld JC. Cloning and characterization of IL-10-related T cell-derived inducible factor (IL-TIF), a novel cytokine structurally related to IL-10 and inducible by IL-9. J Immunol. 2000; 164(4):1814-9. doi: 10.4049/jimmunol.164.4.1814 PMID: 10657629
5. Dumoutier L, Van Roost E, Colau D, Renauld JC. Human interleukin-10-related T cell-derived inducible factor: molecular cloning and functional characterization as an hepatocyte-stimulating factor. Proc Natl Acad Sci U S A. 2000; 97(18):10144-9. doi: 10.1073/pnas.170291697 PMID: 10954742
6. Lecart S, Morel F, Noraz N, Pene J, Garcia M, Boniface K, et al. IL-22, in contrast to IL-10, does not induce Ig production, due to absence of a functional IL-22 receptor on activated human B cells. Int Immunol. 2002; 14(11):1351-6. doi: 10.1093/intimm/dxf096 PMID: 12407026
7. Boniface K, Bernard FX, Garcia M, Gurney AL, Lecron JC, Morel F. IL-22 inhibits epidermal differentiation and induces proinflammatory gene expression and migration of human keratinocytes. J Immunol. 2005; 174(6):3695-702. doi: 10.4049/jimmunol.174.6.3695 PMID: 15749908
8. Brand S, Dambacher J, Beigel F, Zitzmann K, Heeg MH, Weiss TS, et al. IL-22-mediated liver cell regeneration is abrogated by SOCS-1/3 overexpression in vitro. Am J Physiol Gastrointest Liver Physiol. 2007; 292(4):G1019-28. doi: 10.1152/ajpgi.00239.2006 PMID: 17204547
9. Aggarwal S, Xie MH, Maruoka M, Foster J, Gurney AL. Acinar cells of the pancreas are a target of inter-leukin-22. J Interferon Cytokine Res. 2001; 21(12):1047-53. doi: 10.1089/107999001317205178PMID: 11798462
10. Whittington HA, Armstrong L, Uppington KM, Millar AB. Interleukin-22: a potential immunomodulatory molecule in the lung. Am J Respir Cell Mol Biol. 2004; 31(2):220-6. doi: 10.1165/rcmb.2003-0285OC PMID: 15039135
11. Gurney AL. IL-22, a Th1 cytokine that targets the pancreas and select other peripheral tissues. Int Immunopharmacol. 2004; 4(5):669-77. doi: 10.1016/j.intimp.2004.01.016 PMID: 15120651
12. Nagalakshmi ML, Rascle A, Zurawski S, Menon S, de Waal Malefyt R. Interleukin-22 activates STAT3 and induces IL-10 by colon epithelial cells. Int Immunopharmacol. 2004; 4(5):679-91. doi: 10.1016/j. intimp.2004.01.008 PMID: 15120652
13. Lejeune D, Dumoutier L, Constantinescu S, Kruijer W, Schuringa JJ, Renauld JC. Interleukin-22 (IL-22) activates the JAK/STAT, ERK, JNK, and p38 MAP kinase pathways in a rat hepatoma cell line. Pathways that are shared with and distinct from IL-10. J Biol Chem. 2002; 277(37):33676-82. doi: 10.1074/ jbc.M204204200 PMID: 12087100
14. Dumoutier L, de Meester C, Tavernier J, Renauld JC. New activation modus of STAT3: a tyrosine-less region of the interleukin-22 receptor recruits STAT3 by interacting with its coiled-coil domain. J Biol Chem. 2009; 284(39):26377-84. doi: 10.1074/jbc.M109.007955 PMID: 19632985
15. Sabat R, OuyangW, Wolk K. Therapeutic opportunities of the IL-22-IL-22R1 system. Nat Rev Drug Discov. 2013; 13(1):21-38. doi: 10.1038/nrd4176
16. Mitra A, Raychaudhuri SK, Raychaudhuri SP. IL-22 induced cell proliferation is regulated by PI3K/Akt/ mTOR signaling cascade. Cytokine. 2012; 60(1):38-42. doi: 10.1016/j.cyto.2012.06.316 PMID: 22840496
17. Guilloteau K, Paris I, Pedretti N, Boniface K, Juchaux F, Huguier V, et al. Skin Inflammation Induced by the Synergistic Action of IL-17A, IL-22, Oncostatin M, IL-1{alpha}, and TNF-{alpha} Recapitulates Some Features of Psoriasis. J Immunol. 2010; 184(9):5263-70. doi: 10.4049/jimmunol.0902464
18. Boniface K, Guignouard E, Pedretti N, Garcia M, Delwail A, Bernard FX, et al. A role for T cell-derived interleukin 22 in psoriatic skin inflammation. Clin Exp Immunol. 2007; 150(3):407- 15. doi: 10.1111/j. 1365-2249.2007.03511.x PMID: 17900301
19. Rabeony H, Petit-Paris I, Garnier J, Barrault C, Pedretti N, Guilloteau K, et al. Inhibition of Keratinocyte Differentiation by the Synergistic Effect of IL-17A, IL-22, IL-1alpha, TNFalpha and Oncostatin M. PLoS One. 2014; 9(7):e101937. doi: 10.1371/journal.pone.0101937 PMID: 25010647
20. Zhang W, Chen Y, Wei H, Zheng C, Sun R, Zhang J, et al. Antiapoptotic activity of autocrine interleukin-22 and therapeutic effects of interleukin-22-small interfering RNA on human lung cancer xenografts. Clin Cancer Res. 2008; 14(20):6432-9. doi: 10.1158/1078-0432.CCR-07-4401 PMID: 18927282
21. Fukui H, Zhang X, Sun C, Hara K, Kikuchi S, Yamasaki T, et al. IL-22 produced by cancer-associated fibroblasts promotes gastric cancer cell invasion via STAT3 and ERK signaling. Br J Cancer. 2014; 111 (4):763-71. doi: 10.1038/bjc.2014.336 PMID: 24937671
22. Jiang R, Wang H, Deng L, Hou J, Shi R, Yao M, et al. IL-22 is related to development of human colon cancer by activation of STAT3. BMC Cancer. 2013; 13:59. doi: 10.1186/1471-2407-13-59 PMID: 23379788
23. Wu T, Cui L, Liang Z, Liu C, Liu Y, Li J. Elevated serum IL-22 levels correlate with chemoresistant condition of colorectal cancer. Clin Immunol. 2013; 147(1):38-9. doi: 10.1016/j.clim.2013.02.007 PMID: 23501837
24. Curd LM, Favors SE, Gregg RK. Pro-tumour activity of interleukin-22 in HPAFII human pancreatic cancer cells. Clin Exp Immunol. 2012; 168(2):192-9. doi: 10.1111/j.1365-2249.2012.04570.x PMID: 22471280
25. Wen Z, Liao Q, Zhao J, Hu Y, You L, Lu Z, et al. High expression of interleukin-22 and its receptor predicts poor prognosis in pancreatic ductal adenocarcinoma. Ann Surg Oncol. 2014; 21(1):125-32. doi: 10.1245/s10434-013-3322-x PMID: 24132627
26. Jiang R, Tan Z, Deng L, Chen Y, Xia Y, Gao Y, et al. Interleukin-22 promotes human hepatocellular carcinoma by activation of STAT3. Hepatology. 2011; 54(3):900-9. doi: 10.1002/hep.24486 PMID: 21674558
27. Petanidis S, Anestakis D, Argyraki M, Hadzopoulou-Cladaras M, Salifoglou A. Differential expression of IL-17, 22 and 23 in the progression of colorectal cancer in patients with K-ras mutation: Ras signal inhibition and crosstalk with GM-CSF and IFN-gamma. PLoS One. 2013; 8(9):e73616. doi: 10.1371/ journal.pone.0073616 PMID: 24040001
28. Kebir H, Kreymborg K, Ifergan I, Dodelet-Devillers A, Cayrol R, Bernard M, et al. Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation. Nat Med. 2007; 13(10):1173-5. doi: 10.1038/nm1651 PMID: 17828272
29. Wainwright DA, Sengupta S, Han Y, Ulasov IV, Lesniak MS. The presence of IL-17A and T helper 17 cells in experimental mouse brain tumors and human glioma. PLoS One. 2010; 5(10):e15390. doi: 10. 1371/journal.pone.0015390 PMID: 21060663
30. Wechsler-Reya R, Scott MP. The developmental biology of brain tumors. Annu Rev Neurosci. 2001; 24:385-428. doi: 10.1146/annurev.neuro.24.1.385 PMID: 11283316
31. Reya T, Morrison SJ, Clarke MF, Weissman IL. Stem cells, cancer, and cancer stem cells. Nature. 2001; 414(6859):105-11. doi: 10.1038/35102167 PMID: 11689955
32. Sanai N, Alvarez-Buylla A, Berger MS. Neural stem cells and the origin of gliomas. N Engl J Med. 2005; 353(8):811-22. doi: 10.1056/NEJMra043666 PMID: 16120861
33. Villalva C, Martin-Lanneree S, Cortes U, Dkhissi F, Wager M, Le Corf A, et al. STAT3 is essential for the maintenance of neurosphere-initiating tumor cells in patients with glioblastomas: a potential for targeted therapy? Int J Cancer. 2011; 128(4):826-38. doi: 10.1002/ijc.25416 PMID: 20473906
34. Giraud S, Bessette B, Boda C, Lalloue F, Petit D, Mathonnet M, et al. In vitro apoptotic induction of human glioblastoma cells by Fas ligand plus etoposide and in vivo antitumour activity of combined drugs in xenografted nude rats. Int J Oncol. 2007; 30(1):273-81. doi: 10.3892/ijo.30.1.273 PMID: 17143538
35. Cheray M, Petit D, Forestier L, Karayan-Tapon L, Maftah A, Jauberteau MO, et al. Glycosylation-related gene expression is linked to differentiation status in glioblastomas undifferentiated cells. Cancer Lett. 2011; 312(1):24-32. doi: 10.1016/j.canlet.2011.07.027 PMID: 21899947
36. Ye ZJ, Zhou Q, Yin W, Yuan ML, Yang WB, Xiang F, et al. Interleukin 22-producing CD4+ T cells in malignant pleural effusion. Cancer Lett. 2012; 326(1):23-32. doi: 10.1016/j.canlet.2012.07.013 PMID: 22809567
37. Kim K, Kim G, Kim JY, Yun HJ, Lim SC, Choi HS. Interleukin-22 promotes epithelial cell transformation and breast tumorigenesis via MAP3K8 activation. Carcinogenesis. 2014; 35(6):1352-61. doi: 10.1093/ carcin/bgu044 PMID: 24517997
38. Weber GF, Gaertner FC, Erl W, Janssen KP, Blechert B, Holzmann B, et al. IL-22-mediated tumor growth reduction correlates with inhibition of ERK1/2 and AKT phosphorylation and induction of cell cycle arrest in the G2-M phase. J Immunol. 2006; 177(11):8266-72. doi: 10.4049/jimmunol.177.11. 8266 PMID: 17114505
39. Zhang F, Shang D, Zhang Y, Tian Y. Interleukin-22 suppresses the growth of A498 renal cell carcinoma cells via regulation of STAT1 pathway. PLoS One. 2011; 6(5):e20382. doi: 10.1371/journal.pone. 0020382 PMID: 21625390
40. Kronblad A, Hedenfalk I, Nilsson E, Pahlman S, Landberg G. ERK1/2 inhibition increases antiestrogen treatment efficacy by interfering with hypoxia-induced downregulation of ERalpha: a combination therapy potentially targeting hypoxic and dormant tumor cells. Oncogene. 2005; 24(45):6835-41. doi: 10. 1038/sj.onc.1208830 PMID: 16007158
41. Chen YL, Lin PC, Chen SP, Lin CC, Tsai NM, Cheng YL, et al. Activation of nonsteroidal anti-inflammatory drug-activated gene-1 via extracellular signal-regulated kinase 1/2 mitogen-activated protein kinase revealed a isochaihulactone-triggered apoptotic pathway in human lung cancer A549 cells. J Pharmacol Exp Ther. 2007; 323(2):746-56. doi: 10.1124/jpet.107.126193 PMID: 17715378
42. Tewari R, Sharma V, Koul N, Sen E. Involvement of miltefosine-mediated ERK activation in glioma cell apoptosis through Fas regulation. J Neurochem. 2008; 107(3):616-27. doi: 10.1111/j.1471-4159.2008. 05625.x PMID: 18710416
43. Cha JH, Choi YJ, Cha SH, Choi CH, Cho WH. Allicin inhibits cell growth and induces apoptosis in U87MG human glioblastoma cells through an ERK-dependent pathway. Oncol Rep. 2012; 28(1):41-8. doi: 10.3892/or.2012.1772 PMID: 22552443
44. Naher L, Kiyoshima T, Kobayashi I, Wada H, Nagata K, Fujiwara H, et al. STAT3 signal transduction through interleukin-22 in oral squamous cell carcinoma. Int J Oncol. 2012; 41(5):1577-86. doi: 10. 3892/ijo.2012.1594 PMID: 22922995
45. Kim G, Ouzounova M, Quraishi AA, Davis A, Tawakkol N, Clouthier SG, et al. SOCS3-mediated regulation of inflammatory cytokines in PTEN and p53 inactivated triple negative breast cancer model. Oncogene. 2015; 34(6):671-80. doi: 10.1038/onc.2014.4 PMID: 24531711
46. Yeh HH, Lai WW, Chen HH, Liu HS, Su WC. Autocrine IL-6-induced Stat3 activation contributes to the pathogenesis of lung adenocarcinoma and malignant pleural effusion. Oncogene. 2006; 25(31):4300-9. doi: 10.1038/sj.onc.1209464 PMID: 16518408
47. Todaro M, Zerilli M, Ricci-Vitiani L, Bini M, Perez Alea M, Maria Florena A, et al. Autocrine production of interleukin-4 and interleukin-10 is required for survival and growth of thyroid cancer cells. Cancer Res. 2006; 66(3):1491-9. doi: 10.1158/0008-5472.CAN-05-2514 PMID: 16452205
48. Zhu VF, Yang J, Lebrun DG, Li M. Understanding the role of cytokines in Glioblastoma Multiforme pathogenesis. Cancer Lett. 2012; 316(2):139-50. doi: 10.1016/j.canlet.2011.11.001 PMID: 22075379
49. Li R, Li G, Deng L, Liu Q, Dai J, Shen J, et al. IL-6 augments the invasiveness of U87MG human glioblastoma multiforme cells via up-regulation of MMP-2 and fascin-1. Oncol Rep. 2010; 23(6):1553-9. doi: 10.3892/or-00000795 PMID: 20428809
50. Tchirkov A, Rolhion C, Bertrand S, Dore JF, Dubost JJ, Verrelle P. IL-6 gene amplification and expression in human glioblastomas. Br J Cancer. 2001; 85(4):518-22. doi: 10.1054/bjoc.2001.1942 PMID: 11506489
51. Qiu B, Zhang D, Wang C, Tao J, Tie X, Qiao Y, et al. IL-10 and TGF-beta2 are overexpressed in tumor spheres cultured from human gliomas. Mol Biol Rep. 2011; 38(5):3585-91. doi: 10.1007/s11033-010-0469-4 PMID: 21088899
52. de Waal Malefyt R, Haanen J, Spits H, Roncarolo MG, te Velde A, Figdor C, et al. Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigenpresenting capacity of monocytes via downregulation of class II major histocompatibility complex expression. J Exp Med. 1991; 174(4):915-24. PMID: 1655948